Anatomy and Neuroscience - Theses
Permanent URI for this collection
Search Results
1 - 1 of 1
-
ItemRetinal dysfunction in an animal model of retinopathy of prematurity( 2012)Retinopathy of prematurity (ROP) is characterised by retinal neovascularisation and visual impairment following high oxygen treatment of premature infants. While attempts to develop new therapies to reduce the severity of ROP are underway, the main method of treatment involves laser photocoagulation of the peripheral retina. This treatment is invasive and can lead to further visual impediments, highlighting the necessity of developing new, less invasive therapeutic treatments to effectively manage ROP. One potential treatment of emerging interest involves blockade of the renin-angiotensin system (RAS). Blockade of the RAS in animal models of ROP have been shown to reduce retinal neovascularisation, inflammatory responses, and, to a degree, neuronal degeneration. However the effects of RAS blockade on neuronal function in animal models of ROP remain unknown. Therefore, the aim of this study was to investigate the functional and structural changes in an animal model of ROP and to determine whether RAS inhibition prevented vascular anomalies and neuronal dysfunction. The rat model of ROP, known as oxygen-induced retinopathy (OIR), is a widely used animal model that closely mirrors the characteristic vascular, glial and neuronal abnormalities of human ROP. This study examined whether the putative prorenin receptor antagonist, handle region peptide (HRP), and the angiotensin II type-1 receptor (AT1R) inhibitor, valsartan, prevents neural, glial and vascular anomalies in the OIR rat retina. Immunohistochemical techniques were used with established cell markers to assess whether HRP and valsartan reduced the development of pathological neovascularisation and altered the microglial response in OIR. The functional deficits in OIR rats with and without treatment with RAS inhibitors were assessed using the electroretinogram. Retinal morphology following treatment was evaluated histologically, including retinal layer thicknesses and synapse morphology. To evaluate why RAS inhibition did not improve the neuronal deficits, the effects of high oxygen rearing on retinal development was assessed. Histological techniques were used to examine the morphological development of retinal vasculature, glia and neurons during the high oxygen phase in the OIR model. The results presented highlighted the anti-angiogenic nature of RAS inhibitors in the developing retina and provided further insight into the role of retinal microglia in OIR. This study indicated that OIR rats have deficits in both rod and cone pathway function and that treatment with RAS inhibitors does not improve this functional loss, despite the advantageous effects of RAS blockade upon reducing glio-vascular pathology. In addition, the results from this study showed that the course of retinal development was altered during high oxygen rearing, with changes in vessels, microglia and some neurons observed. In summary, the findings shown in this thesis demonstrate abnormal vascular, glial and neuronal changes during and on removal from the high oxygen phase in the OIR rat model. Despite the beneficial effects RAS inhibitors had on reducing the vascular pathology, visual function in these rats was not improved following treatment. The retinal changes that occur during the high oxygen phase, prior to pathological neovascularisation and RAS inhibition, may contribute to these deficits. These findings have implications for the treatment of ROP. Notably, future therapies need to target pathological angiogenesis, whilst promoting physiological growth of vessels into the retina. Moreover, preventing the neuronal changes that occur during high oxygen exposure may need to be considered in order to maximise visual outcomes for infants with ROP.